Ascendis Pharma A/S (ASND)
270.56
-0.56
(-0.21%)
USD |
NASDAQ |
Sep 04, 16:00
271.49
+0.93
(+0.34%)
After-Hours: 20:00
Ascendis Pharma Cash and Short Term Investments (Annual) : 723.51M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 723.51M |
| December 31, 2024 | 579.41M |
| December 31, 2023 | 441.24M |
| December 31, 2022 | 784.91M |
| December 31, 2021 | 775.64M |
| December 31, 2020 | 879.48M |
| December 31, 2019 | 671.37M |
| Date | Value |
|---|---|
| December 31, 2018 | 317.64M |
| December 31, 2017 | 234.58M |
| December 31, 2016 | 190.20M |
| December 31, 2015 | 129.97M |
| December 31, 2014 | 60.70M |
| December 31, 2013 | 26.77M |
| December 31, 2012 | 19.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Evaxion AS | 23.23M |
| BioMarin Pharmaceutical, Inc. | 1.561B |
| Genmab A/S | 1.715B |
| Zealand Pharma A/S | 2.376B |
| Cellectis SA | 208.66M |